COVIDSEQ
Illumina, Inc.
Application Filed: 2020-04-24
Trademark Application Details
STATEMENT OF USE - TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88983895 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Susan M. Natland |
| Attorney Docket Number | ILLINCT.690T |
| Law Office Assigned | M90 |
| Employee Name | HUSSAIN, TASNEEM |
Timeline
| 2020-04-24 | Application Filed |
| 2020-05-14 | Date of First Use |
| 2021-06-08 | Published for Opposition |
| 2022-03-03 | Location: TMO LAW OFFICE 118 |
| 2022-03-03 | Status: Live/Pending |
| 2022-03-03 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Illumina, Inc. |
| Address | 5200 Illumina Way San Diego DE 92122 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Diagnostic agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical use; Diagnostic reagents and preparations for medical use; Kits comprised principally of diagnostic reagents with a protocol for use thereof for medical purposes; Kits comprised of diagnostic nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, biological preparations for medical genetic testing and medical diagnostic purposes; diagnostic agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical use in the fields of medical diagnostics, clinical diagnostics, medical forensics, laboratory medicine, genetic testing, and genetics; all of the foregoing for the detection of or in the field of COVID-19 |
| GS0051 | Diagnostic agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical use; Diagnostic reagents and preparations for medical use; Kits comprised principally of diagnostic reagents with a protocol for use thereof for medical purposes; Kits comprised of diagnostic nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, biological preparations for medical genetic testing and medical diagnostic purposes; diagnostic agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical use in the fields of medical diagnostics, clinical diagnostics, medical forensics, laboratory medicine, genetic testing, and genetics; all of the foregoing for the detection of or in the field of COVID-19 |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2020-04-28 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-05-06 | 2 NWOS I:Incoming Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2020-06-25 | 3 PARI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2020-07-08 | 4 ALIE A:Allowance for Publication |
| PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | 2020-07-09 | 5 AMPX O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2020-10-19 | 6 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-10-21 | 7 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2020-10-21 | 8 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-10-21 | 9 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-04-21 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-04-21 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-04-22 | 12 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2021-04-30 | 13 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2021-04-30 | 14 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-04-30 | 15 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2021-04-30 | 16 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-05-03 | 17 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-05-19 | 18 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2021-06-08 | 19 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-06-08 | 20 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-08-03 | 21 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-02-01 | 22 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2022-02-01 | 23 EXT1 S: |
| EXTENSION 1 GRANTED | 2022-02-01 | 24 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-02-03 | 25 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2022-02-16 | 26 EISU I:Incoming Correspondence |
| TEAS REQUEST TO DIVIDE RECEIVED | 2022-02-16 | 27 ERTD I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2022-03-03 | 28 AITU A:Allowance for Publication |
| DIVISIONAL REQUEST RECEIVED | 2022-02-16 | 29 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2022-03-03 | 30 DPCC D:Assigned to Examiner |
| USE AMENDMENT FILED | 2022-02-16 | 31 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2022-03-03 | 32 SUPC I:Incoming Correspondence |
| SU - NON-FINAL ACTION - WRITTEN | 2022-03-08 | 33 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2022-03-08 | 34 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-03-08 | 35 GNRN O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2022-07-20 | 36 EEXT I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-09-07 | 37 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2022-09-19 | 38 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-09-19 | 39 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-09-19 | 40 TEME I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2022-09-19 | 41 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2022-09-20 | 42 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2022-10-25 | 43 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-10-25 | 44 NRCC E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 COVIDSEQ 88983895 not registered Live/Pending |
Illumina, Inc. 2020-04-24 |
 COVIDSEQ 88887319 not registered Live/Pending |
Illumina Inc. 2020-04-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 